期刊
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
卷 279, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.resp.2020.103476
关键词
Silent hypoxemia; High-altitude hypoxia; Hypoxic acclimatization; Acute respiratory distress; Respiratory system
资金
- Fonds de recherche du Quebec-Sante (FRQ-S) [FQ121919]
- IUCPQ Foundation
- NHMRC [APP1165529]
A very recent epidemiological study provides preliminary evidence that living in habitats located at 2500 m above sea level (mass) might protect from the development of severe respiratory symptoms following infection with the novel SARS-CoV-2 virus. This epidemiological finding raises the question of whether physiological mechanisms underlying the acclimatization to high altitude identifies therapeutic targets for the effective treatment of severe acute respiratory syndrome pivotal to the reduction of global mortality during the COVID-19 pandemic. This article compares the symptoms of acute mountain sickness (AMS) with those of SARS-CoV-2 infection and explores overlapping patho-physiological mechanisms of the respiratory system including impaired oxygen transport, pulmonary gas exchange and brainstem circuits controlling respiration. In this context, we also discuss the potential impact of SARS-CoV-2 infection on oxygen sensing in the carotid body. Finally, since erythropoietin (EPO) is an effective prophylactic treatment for AMS, this article reviews the potential benefits of implementing FDA-approved erythropoietin-based (EPO) drug therapies to counteract a variety of acute respiratory and non-respiratory (e.g. excessive inflammation of vascular beds) symptoms of SARS-CoV-2 infection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据